EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 14 July 2022

Gap between EU vision and national competencies affects health agenda

Lars Fruergaard Jørgensen, CEO of Novo Nordisk and first vice-president of EFPIA

"It’s interesting to reflect that the industry brought five different vaccines in record time, all of those based on a certain degree of innovation (...). Next time around, we have to be lucky again that somebody else has invested in some science that is ready to be used. We also scaled up manufacturing in record time, so that billions of doses were basically available for the whole world. (...)

Still, there is a political agenda in the Western world to feel maybe some sort of bad conscience and they are proposing to waver IP rights in future situations. I get a bit emotional because I think this is politics at its worst, as it’s not helping anyone. It’s actually destroying the incentive to make the next version of vaccine or cure we all need."

Read more

News

EFPIA statement on the EU4Health 2023 work program
12 July 2022

By funding strategic initiatives with clear EU added value, the EU4Health program can support Member States in transforming... Read more

Blogs

Social consensus on extending screening programs and the right to be forgetten
13 July 2022

A guest blog by Forum of International R&D Pharmaceutical Companies, Slovenia Read more

Leaving no stone unturned — Europe beating cancer, together
12 July 2022 - Ivana Cattaneo - Marie-Sharmila Blandino - Aikaterini Fameli

The EU’s ambitious goals to protect cancer patients could transform lives and save millions more. A properly-implemented... Read more

Animal use and welfare in pharmaceutical R&D

The pharmaceutical industry is committed to responsible animal use, with tangible outcomes leading to improved animal welfare and high-quality science. Check our report for a list of over 70 examples of 3Rs (Replace, Reduce, Refine) in action.

What we are reading

Voice of EHDEN
On 11 July 2022 (Anchor, by Spotify)

In this podcast experts will discuss key aspects of working with real world health data in large scale observational... Read more

Innovation or stagnation? EU pharma industry at a crossroads ahead of rules revision
On 08 July 2022 (Euractiv)

War, COVID-19 pandemic and vulnerability of supply chains are pushing the EU to be more resilient and self-sufficient... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu